PL366773A1 - Kopolimer blokowy o zmniejszonej zawartości zanieczyszczeń, nośnik polimerowy, preparaty farmaceutyczne w postaci polimeru i proces ich wytwarzania - Google Patents

Kopolimer blokowy o zmniejszonej zawartości zanieczyszczeń, nośnik polimerowy, preparaty farmaceutyczne w postaci polimeru i proces ich wytwarzania

Info

Publication number
PL366773A1
PL366773A1 PL02366773A PL36677302A PL366773A1 PL 366773 A1 PL366773 A1 PL 366773A1 PL 02366773 A PL02366773 A PL 02366773A PL 36677302 A PL36677302 A PL 36677302A PL 366773 A1 PL366773 A1 PL 366773A1
Authority
PL
Poland
Prior art keywords
preparation
block copolymer
polymeric
carrier
same
Prior art date
Application number
PL02366773A
Other languages
English (en)
Other versions
PL222061B1 (pl
Inventor
Takeshi Nakanishi
Kazuhisa Shimizu
Ryuji Uehara
Masanobu Suzuki
Megumi Machida
Tomoko Akutsu
Shigeto Fukushima
Original Assignee
Nippon Kayaku Kabushiki Kaisha
Japan Science And Technology Agency
Sakurai Yasuhisa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Kabushiki Kaisha, Japan Science And Technology Agency, Sakurai Yasuhisa filed Critical Nippon Kayaku Kabushiki Kaisha
Publication of PL366773A1 publication Critical patent/PL366773A1/pl
Publication of PL222061B1 publication Critical patent/PL222061B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/40—Polyamides containing oxygen in the form of ether groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Polyamides (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyethers (AREA)
  • Materials For Medical Uses (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
PL366773A 2001-06-20 2002-06-19 Sposób produkcji kopolimeru blokowego, nośnik polimerowy oraz polimerowy preparat farmaceutyczny PL222061B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001187175 2001-06-20
JP2001187176 2001-06-20

Publications (2)

Publication Number Publication Date
PL366773A1 true PL366773A1 (pl) 2005-02-07
PL222061B1 PL222061B1 (pl) 2016-06-30

Family

ID=26617300

Family Applications (1)

Application Number Title Priority Date Filing Date
PL366773A PL222061B1 (pl) 2001-06-20 2002-06-19 Sposób produkcji kopolimeru blokowego, nośnik polimerowy oraz polimerowy preparat farmaceutyczny

Country Status (13)

Country Link
US (1) US7138490B2 (pl)
EP (1) EP1408066B1 (pl)
JP (1) JP4462928B2 (pl)
KR (1) KR100924990B1 (pl)
CN (1) CN100378140C (pl)
AT (1) ATE462746T1 (pl)
AU (1) AU2002346296B2 (pl)
CA (1) CA2450448C (pl)
DE (1) DE60235812D1 (pl)
ES (1) ES2343679T3 (pl)
PL (1) PL222061B1 (pl)
RU (1) RU2282641C2 (pl)
WO (1) WO2003000771A1 (pl)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2502870C (en) * 2002-10-31 2011-07-26 Nippon Kayaku Kabushiki Kaisha High-molecular weight derivatives of camptothecins
JP4535229B2 (ja) * 2003-05-08 2010-09-01 国立大学法人 東京大学 ポリエチレングリコール−ポリカチオンブロック共重合体
JP4763459B2 (ja) * 2003-05-29 2011-08-31 株式会社東京大学Tlo 安定化高分子ミセル
US7410699B2 (en) * 2003-10-10 2008-08-12 Japan Science And Technology Agency Finely particulate composite containing carbon compound encapsulated in a polymer micelle of a block copolymer
CN101023119B (zh) * 2004-09-22 2010-05-05 日本化药株式会社 新型嵌段共聚物,胶束制剂以及含胶束制剂为活性组分的抗癌剂
JPWO2007034795A1 (ja) * 2005-09-20 2009-03-26 株式会社ジェノラックBl γ−ポリグルタミン酸架橋物及びその製造方法
KR20080064827A (ko) 2005-10-05 2008-07-09 도쿄 씨알오 가부시키가이샤 생체 적합성 블록 공중합체, 그 용도 및 제조법
JP5237821B2 (ja) 2005-12-05 2013-07-17 日東電工株式会社 ポリグルタミン酸−アミノ酸結合体および方法
KR20080106254A (ko) 2006-03-28 2008-12-04 니폰 가야꾸 가부시끼가이샤 탁산류의 고분자 결합체
CA2652656A1 (en) 2006-05-18 2007-11-29 Nippon Kayaku Kabushiki Kaisha High-molecular weight conjugate of podophyllotoxins
CA2664852A1 (en) * 2006-10-03 2008-04-10 Nippon Kayaku Kabushiki Kaisha High-molecular weight conjugate of resorcinol derivatives
EP2080779B1 (en) 2006-11-06 2016-05-18 Nippon Kayaku Kabushiki Kaisha Polymeric derivative of nucleic acid metabolic antagonist
EP2090607B1 (en) 2006-11-08 2015-05-20 Nippon Kayaku Kabushiki Kaisha Polymeric derivative of nucleic acid metabolic antagonist
US20080181852A1 (en) * 2007-01-29 2008-07-31 Nitto Denko Corporation Multi-functional Drug Carriers
EP2144631A2 (en) * 2007-04-10 2010-01-20 Nitto Denko Corporation Multi-functional polyglutamate drug carriers
EP2155253A2 (en) * 2007-05-09 2010-02-24 Nitto Denko Corporation Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs
DK2155255T3 (da) * 2007-05-09 2013-09-02 Nitto Denko Corp Sammensætninger der omfatter en hydrofob forbindelse og et polyaminosyrekonjugat
JP2010528122A (ja) * 2007-05-09 2010-08-19 日東電工株式会社 白金薬剤と結合されたポリマー
KR100941774B1 (ko) * 2007-09-06 2010-02-11 성균관대학교산학협력단 인체안전성이 우수한 온도 및 피에치 민감성 블록공중합체및 이의 제조방법과 이를 이용한 약물전달체
US8703878B2 (en) 2007-09-28 2014-04-22 Nippon Kayaku Kabushiki Kaisha High-molecular weight conjugate of steroids
EP2229417B1 (en) * 2007-12-31 2014-07-30 Samyang Biopharmaceuticals Corporation Process for the preparation of highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid
KR20100122510A (ko) * 2008-03-06 2010-11-22 닛토덴코 가부시키가이샤 중합체 파클리탁셀 접합체 및 암 치료 방법
KR101589582B1 (ko) 2008-03-18 2016-01-28 니폰 가야꾸 가부시끼가이샤 생리활성물질의 고분자량 결합체
ES2449865T5 (es) * 2008-04-16 2022-11-18 Momenta Pharmaceuticals Inc Análisis de composiciones de copolímeros de aminoácidos
JP5366940B2 (ja) 2008-05-08 2013-12-11 日本化薬株式会社 葉酸若しくは葉酸誘導体の高分子結合体
CN102037058B (zh) * 2008-05-23 2013-08-07 那野伽利阿株式会社 多西紫杉醇高分子衍生物、及其制造方法及其用途
JP5544357B2 (ja) 2009-05-15 2014-07-09 日本化薬株式会社 水酸基を有する生理活性物質の高分子結合体
JP5856069B2 (ja) 2010-11-17 2016-02-09 日本化薬株式会社 新規なシチジン系代謝拮抗剤の高分子誘導体
WO2013009885A2 (en) 2011-07-11 2013-01-17 Momenta Pharmaceuticals, Inc. Evaluation of copolymer diethylamide
US8575198B1 (en) 2011-09-07 2013-11-05 Momenta Pharmaceuticals, Inc. In-process control for the manufacture of glatiramer acetate
JP5711378B2 (ja) 2011-09-11 2015-04-30 日本化薬株式会社 ブロック共重合体の製造方法
US8691925B2 (en) 2011-09-23 2014-04-08 Az Electronic Materials (Luxembourg) S.A.R.L. Compositions of neutral layer for directed self assembly block copolymers and processes thereof
US8686109B2 (en) * 2012-03-09 2014-04-01 Az Electronic Materials (Luxembourg) S.A.R.L. Methods and materials for removing metals in block copolymers
US10457088B2 (en) 2013-05-13 2019-10-29 Ridgefield Acquisition Template for self assembly and method of making a self assembled pattern
US9093263B2 (en) 2013-09-27 2015-07-28 Az Electronic Materials (Luxembourg) S.A.R.L. Underlayer composition for promoting self assembly and method of making and using
KR20150066151A (ko) 2013-12-06 2015-06-16 삼성전자주식회사 블록 공중합체의 정제 방법 및 블록 공중합체를 이용한 패턴 형성 방법
US9181449B2 (en) 2013-12-16 2015-11-10 Az Electronic Materials (Luxembourg) S.A.R.L. Underlayer composition for promoting self assembly and method of making and using
CN104109235B (zh) * 2014-05-30 2017-07-18 厦门赛诺邦格生物科技股份有限公司 一种具有氮原子支化中心的单一官能化聚乙二醇、制备方法及其生物相关物质
KR101726728B1 (ko) 2015-07-28 2017-04-14 주식회사 삼양바이오팜 고분자 담체 함유 약학 조성물의 유연물질 분석 방법
US10945997B2 (en) 2016-01-08 2021-03-16 Nippon Kayaku Kabushiki Kaisha Polymer derivative of macrolide immunosuppressant
JP6997764B2 (ja) 2016-08-18 2022-01-18 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 自己組織化用途用のポリマー組成物
JP6835969B2 (ja) 2016-12-21 2021-02-24 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung ブロックコポリマーの自己組織化のための新規組成物及び方法
CN107313258A (zh) * 2017-06-23 2017-11-03 安徽金钻智能科技有限公司 一种蚕丝织物精炼用低泡耐碱渗透剂
JP7269346B2 (ja) 2018-12-07 2023-05-08 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング ポリスチレン-b-ポリ(メチルメタクリレート)ジブロックコポリマーのコンタクトホール自己集合のための高速架橋可能な中性下層及びそれらの調合物
US20250179245A1 (en) * 2022-03-17 2025-06-05 Nof Corporation Method for producing polyethylene glycol derivative
CN115894905B (zh) * 2022-08-30 2023-08-08 山东华铂凯盛生物科技有限公司 一种高纯度窄分子量分布的甲氧基聚乙二醇-聚(l-谷氨酸钠)的制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2517760B2 (ja) * 1989-05-11 1996-07-24 新技術事業団 水溶性高分子化医薬製剤
AU636481B2 (en) * 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
JP3111099B2 (ja) * 1991-10-31 2000-11-20 科学技術振興事業団 水溶性高分子化薬剤の製造法
JP3270592B2 (ja) 1992-10-26 2002-04-02 日本化薬株式会社 ブロック共重合体−抗癌剤複合体医薬製剤
JP3268913B2 (ja) 1992-10-27 2002-03-25 日本化薬株式会社 高分子担体
JP3682475B2 (ja) 1993-08-31 2005-08-10 靖久 桜井 水溶性抗癌剤
WO1997012895A1 (fr) 1995-09-29 1997-04-10 Japan Science And Technology Corporation Nouveaux derives de composes d'anthracycline, et preparations medicamenteuses les contenant

Also Published As

Publication number Publication date
EP1408066A4 (en) 2004-09-29
AU2002346296B2 (en) 2007-09-13
US7138490B2 (en) 2006-11-21
EP1408066A1 (en) 2004-04-14
KR100924990B1 (ko) 2009-11-04
PL222061B1 (pl) 2016-06-30
EP1408066B1 (en) 2010-03-31
ATE462746T1 (de) 2010-04-15
RU2282641C2 (ru) 2006-08-27
JP4462928B2 (ja) 2010-05-12
KR20040030693A (ko) 2004-04-09
CN1518573A (zh) 2004-08-04
DE60235812D1 (de) 2010-05-12
CA2450448A1 (en) 2003-01-03
CN100378140C (zh) 2008-04-02
JPWO2003000771A1 (ja) 2004-10-07
CA2450448C (en) 2011-12-13
US20040151690A1 (en) 2004-08-05
WO2003000771A1 (fr) 2003-01-03
RU2004101281A (ru) 2005-06-27
ES2343679T3 (es) 2010-08-06

Similar Documents

Publication Publication Date Title
ATE462746T1 (de) Blockcopolymer mit verringertem verunreinigungsgehalt, polymerer träger, pharmazeutische zubereitungen in polymerer form und verfahren zur herstellung davon
BR9610838A (pt) Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização.
AU2002346296A1 (en) Block copolymer reduced in impurity content, polymeric carrier, pharmaceutical preparations in polymeric form and process for the preparation of the same
WO1998007745A3 (en) Compositions and methods for treating infections using analogues of indolicidin
MY113490A (en) Modified anti-icam-1 antibodies and their use in the treatment of inflammation
WO1991014437A3 (en) Use of copper(ii) containing compounds to accelerate wound healing
EP1133989A3 (en) Polymer compositions for use in therapy
AU2002248384A1 (en) Serpin drugs for treatment of hiv infection and method of use thereof
WO2003015809A3 (en) Antimicrobial cationic peptides and formulations thereof
CA2427227A1 (en) Lactam compound
IL126917A0 (en) A method for treating viral infections and a pharmaceutical composition for treating the same
BG101118A (en) Therapeutical compounds
WO1998001158A3 (de) Hämoglobin-hydroxyethylstärke-konjugate als sauerstoff-transport-mittel
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
CA2300679A1 (en) Method of reducing intestinal gas, cramping and anorectal irritation
DE69428350D1 (en) Polymere ionene als anthelminthika in tieren
ATE290548T1 (de) Expressionsblockierung von virulenten faktoren in s. aureus
CA2221900A1 (en) Use of trospium chloride and 2-component system for the same
AUPQ425699A0 (en) A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
AU533524B2 (en) 6-substituted-11-alkylene morphanthridines
NO984920D0 (no) Sammensetninger omfattende en nitroneforbindelse for anvendelse ved behandling av okulµr inflammasjon
DK0769056T3 (da) Ikke-splejsende verianter af gp350/220
WO2000063386A3 (en) Prevention, diagnosis and treatment of lyme disease
WO2001034174A3 (en) Methods for administration of therapeutic agents on an antiangiogenic schedule